Literature DB >> 194005

The effect of sodium azide on the chemiluminescence of granulocytes--evidence for the generation of multiple oxygen radicals.

A L Sagone, D S Mendelson, E N Metz.   

Abstract

It has been established that granulocytes generate superoxide (O-2) as well as hydrogen peroxide (H2O2) during phagocytosis. The chemiluminescence (CL) generated by phagocytes appears dependent on these oxygen radicals (or). however, recent studies suggest that oxygen molecules, including singlet oxygen (1O2) or hydroxyl radicals (OH-), may also be generated during phagocytosis and contribute to CL. We have tested this possibility by studying human granulocyte CL in the presence of 0.1 mM sodium azide, a known inhibitor of myeloperoxidase and catalase and a scavenger of 1O2. The effects of azide on CL were correlated with the effects of this compound on hexose monophosphate shunt (hmps) activity, nitroblue tetrazolium (NBT) dye reduction, formate oxidation, and cytochrome c reduction. CL generated by granulocytes during the phagocytosis of zymosan particles was markedly impaired by azide (24% to 47% of control values). On the other hand, phenomena dependent in part on the presence of O2 radicals, i.e., reduction of NBT dye and cytochrome c, were not impaired by the presence of azide. As would be expected, inhibition of catalase by azide virtually abolished the oxidation of formate, but the burst in HMPS activity associated with phagocytosis was augmented further. The latter observation indicated that azide did not impair generation of H2O2 but increased the relative amount detoxified via the HMPS. The experiment provides evidence that radicals other than O-2 and H2O2 are generated during phagocytosis and that these radicals are major contributors to the CL phenomenon.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194005

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  16 in total

1.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

3.  Analysis of the bimodal chemiluminescence pattern stimulated in human neutrophils by chemotactic factors.

Authors:  J G Bender; D E Van Epps
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

4.  Simple procedure for measuring neutrophil chemiluminescence.

Authors:  E Prendergast; R A Proctor
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

5.  Luminol-independent chemiluminescence by phagocytes is markedly enhanced by dexamethasone, not by other glucocorticosteroids.

Authors:  Y Niwa; K Somiya; Y Miyachi; T Kanoh; T Sakane
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

6.  The role of reactive oxygen intermediates in nonspecific monocyte cytotoxicity induced by immune complexes.

Authors:  J R Geffner; M Giordano; G Serebrinsky; M Isturiz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

7.  Regulation of superoxide generation by myeloperoxidase during the respiratory burst of human neutrophils.

Authors:  S W Edwards; T F Swan
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

8.  Evidence that OH. production by human PMNs is related to prostaglandin metabolism.

Authors:  A L Sagone; R M Wells; C DeMocko
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

9.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

10.  [Luminol chemiluminescence of phagocytosing polymorphonuclear leukocytes (author's transl)].

Authors:  C Eschenbach
Journal:  Klin Wochenschr       Date:  1982-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.